Optiver Holding
ZURA icon

Optiver Holding’s Zura Bio ZURA Stock Holding History

Optiver Holding’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$95 Hold
16
– – ﹤0.01% 2241
2025
Q4 		$84 Hold
16
– – ﹤0.01% 2378
2025
Q3 		$69 Buy
+16
New +$29 ﹤0.01% 2610

Other funds holding ZURA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Optiver Holding's ZURA Position: Q1 2026 in Review

Optiver Holding held its Zura Bio (ZURA) position steady in Q1 2026 at 16 shares worth $95. The position accounts for ﹤0.01% of the portfolio, ranked #2241.

Optiver Holding first reported a position in ZURA in Q3 2025 and has held it in 3 quarters since. 94 funds tracked by Wall St. Rank hold ZURA as of Q1 2026.

  • Optiver Holding held 16 shares of Zura Bio worth $95 as of Q1 2026.
  • Optiver Holding left its Zura Bio share count unchanged in Q1 2026.
  • Zura Bio made up ﹤0.01% of Optiver Holding's portfolio in Q1 2026, its #2241 holding.
  • Optiver Holding first reported a position in Zura Bio in Q3 2025 and has held it in 3 quarters since.
  • 94 funds tracked by Wall St. Rank held Zura Bio as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.